Skip to content

Clinical trials

Hemolysis trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemolysis Status: Unknown status Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20122
20141
20161
20172
20191
20201
20222
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charles University, Czech Republic2
Ahram Canadian University1
Amsterdam UMC, location VUmc1
Assistance Publique - Hôpitaux de Paris1
Assiut University1
CARE Pharma Shanghai Ltd.1
Cardiologie et Développement1
Centro Medico Campinas1
China National Biotec Group Company Limited1
First Affiliated Hospital, Sun Yat-Sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemolysis19
Anemia2
Anemia, Sickle Cell2
Atrial Fibrillation2
Hematologic Diseases2
Anemia, Hemolytic1
Anemia, Hemolytic, Autoimmune1
Arteriovenous Fistula1
Autoimmune Diseases1
COVID-191

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.